Options for Pain Management Using Nonpharmacological Strategies
OPTIONS
2 other identifiers
interventional
296
1 country
1
Brief Summary
The purpose of this study is to help Veterans learn about different ways they can manage chronic pain that do not involve medications. Veterans will work with a coach to explore the Veterans' values and goals and how different non-medication approaches may fit into these values and goals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Nov 2022
Longer than P75 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2022
CompletedFirst Posted
Study publicly available on registry
October 3, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
May 6, 2026
May 1, 2026
3.7 years
September 27, 2022
May 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Interference Brief Pain Inventory (BPI)
The pain interference score from the Brief Pain Inventory averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life. Lower scores are better outcomes.
Change from baseline to 6 months
Secondary Outcomes (7)
Use of Nonpharmacological and Self-Care Approaches (NSCAP)
Change from baseline to 6 months
Patient Activation Measure (PAM)
Change from baseline to 6 months
VR-12
Change from baseline to 6 months
Depression PHQ-8
Change from baseline to 6 months
Anxiety GAD-7
Change from baseline to 6 months
- +2 more secondary outcomes
Study Arms (2)
OPTIONS Intervention Coaching
EXPERIMENTALIntervention participants will participate in a series of four coaching sessions focused on helping patients clarify their values and treatment goals, aligning these values and goals and their lifestyle with nonpharmacological treatment options, working on overcoming barriers to use and adherence of nonpharmacological treatment options (using motivational interviewing), and preparing patients to discuss these options with their primary care providers. A decision aid will be used during these coaching sessions.
OPTIONS Waitlist Control
NO INTERVENTIONParticipants randomized into waitlist control group will receive the intervention decision aid after completing the last survey at 9 months. Participants will also be offered the opportunity to have a brief 20-minute session with a member of the OPTIONS study staff to help walk them through this decision aid.
Interventions
The purpose of this study is to help Veterans learn about different ways they can manage chronic pain that do not involve medications. Veterans will work with a coach to explore their values and goals and how different non-medication approaches may fit into these values and goals.
Eligibility Criteria
You may qualify if:
- have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, or shoulder) for at least 3 months,
- have at least moderate pain intensity and interference with function, defined by a score of 4 (possible range: 0-10) on the PEG, a 3-item measure of pain intensity, interference with enjoyment of life, and interference with general activity (obtained from phone screener),
- have a primary care appointment scheduled or due in approximately the next three months.
- open to trying new pain treatments
You may not qualify if:
- a psychiatric hospitalization in the past 6 months,
- long-term opioid therapy
- severe medical conditions likely precluding participation (e.g., NY Heart Association Class III or IV heart failure) which includes heart attack, stroke, and cancer, or
- if the eligibility screener reveals cognitive impairment, defined by a score of \>3 (possible range: 0-6) on MMSE cognitive screen (obtained from phone screener), or
- if the eligibility screener reveals active suicidal ideation, or
- severe hearing/speech impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana, 46202-2884, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew J. Bair, MD MS
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The assessors will be blinded to the treatment assignment when administering baseline outcome assessments
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2022
First Posted
October 3, 2022
Study Start
November 1, 2022
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
October 31, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share